Advancements in development of novel class of HIV protease inhibitors
Background Protease (PR) inhibitors (PIs) are widely regarded as the most significant agents in the treatment of human immunodeficiency virus (HIV) and have been instrumental in the success of highly active antiretroviral therapy (HAART). The PR enzyme is essential for the viral life cycle, as it cl...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2026-12-01
|
| Series: | Annals of Medicine |
| Assuntos: | |
| Acceso en liña: | https://www.tandfonline.com/doi/10.1080/07853890.2026.2617730 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|